Shopping Cart
- Remove All
- Your shopping cart is currently empty
PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $350 | In Stock | |
5 mg | $828 | In Stock | |
10 mg | $1,130 | In Stock | |
25 mg | $1,590 | In Stock | |
50 mg | $1,980 | In Stock | |
100 mg | $2,500 | In Stock |
Description | PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD). |
Targets&IC50 | β-Amyloid (1–42):1.6 μM |
In vitro | The MTT data for the PPI-1019 using SHY5Y cells after a 24 h aggregation of 10 μM Aβ-(1–42) with IC50 was 10 μM. The N-methylated peptides PPI-1019 show a reduction in cell toxicity at concentrations similar to that used in the thioflavin T assays (IC50=1.6 μM).[1] |
Alias | PPI1019, Apan |
Molecular Weight | 650.85 |
Formula | C36H54N6O5 |
Cas No. | 290828-45-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 1 mg/mL, Sonication is recommended. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.